BRAX — Braxia Scientific Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Braxia Scientific CEO Roger Mcintyre To Join Advisory Board Of At-Home Telemedicine Platform KetaMD
Brief: Braxia Scientific To Commence Canada's First Multiple-Dose Psilocybin Trial For Treatment Resistant Depression
Brief: Braxia Scientific Launches Psilocybin-Assisted Clinical Therapy Training Program
Brief: Braxia Scientific Awarded Government Of Canada Funding To Complete First Of Its Kind Ketamine Clinical Trial For Bipolar Depression
Brief: Champignon Brands To Restate Financial Statements
Brief: Champignon Brands Announces New CFO And New General Counsel
Brief: Champignon Brands Says Roger Mcintyre Elected Board Chair
Brief: Champignon To Acquire Altmed Capital Corp